Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation

Journal of Neurochemistry

Volumn 107, Issue 3, 2008, Pages 636-646

  Iwamaru, Yoshifumi ^a   Shimizu, Yoshihisa ^a   Imamura, Morikazu ^a   Murayama, Yuichi ^a   Endo, Ryo ^a   Tagawa, Yuichi ^a   Ushiki Kaku, Yuko ^b   Takenouchi, Takato ^c   Kitani, Hiroshi ^c   Mohri, Shirou ^a   Yokoyama, Takashi ^a   Okada, Hiroyuki ^a  

^a NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^b NIPPI RESEARCH INSTITUTE OF BIOMATRIX   (Japan)

^c NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

Author keywords

Amyloid; Lactoferrin; N2a cells; Prion; PrPC; PrPSc

Indexed keywords

AMYLOID; LACTOFERRIN; PRION PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG INHIBITION; MOUSE; NONHUMAN; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL;

ANIMALS; BLOTTING, WESTERN; CATTLE; CELL MEMBRANE; CELLS, CULTURED; FLOW CYTOMETRY; LACTOFERRIN; MICE; MICE, TRANSGENIC; PRPC PROTEINS; PRPSC PROTEINS; SCRAPIE;

BOVINAE;

EID: 53749089729     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05628.x     Document Type: Article

References (50)

1. Arnold R. R., Cole M. F. McGhee J. R. (1977) A bactericidal effect for human lactoferrin. Science 197, 263 265.
2. Borchelt D. R., Taraboulos A. Prusiner S. B. (1992) Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem. 267, 16188 16199.
3. Caughey B. Raymond G. J. (1991) The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J. Biol. Chem. 266, 18217 18223.
4. Caughey B. Raymond G. J. (1993) Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J. Virol. 67, 643 650.
5. Caughey B., Raymond G. J., Ernst D. Race R. E. (1991a) N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J. Virol. 65, 6597 6603.
6. Caughey B. W., Dong A., Bhat K. S., Ernst D., Hayes S. F. Caughey W. S. (1991b) Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30, 7672 7680.
7. Caughey W. S., Raymond L. D., Horiuchi M. Caughey B. (1998) Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proc. Natl Acad. Sci. USA 95, 12117 12122.
8. Chen S. G., Teplow D. B., Parchi P., Teller J. K., Gambetti P. Autilio-Gambetti L. (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270, 19173 19180.
9. Crouch S. P., Slater K. J. Fletcher J. (1992) Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80, 235 240.
10. Doh-ura K., Ishikawa K., Murakami-Kubo I., Sasaki K., Mohri S., Race R. Iwaki T. (2004) Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models. J. Virol. 78, 4999 5006.
11. Faucheux B. A., Nillesse N., Damier P. et al. (1995) Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc. Natl Acad. Sci. USA 92, 9603 9607.
12. Feraudet C., Morel N., Simon S., Volland H., Frobert Y., Creminon C., Vilette D., Lehmann S. Grassi J. (2005) Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J. Biol. Chem. 280, 11247 11258.
13. Fillebeen C., Descamps L., Dehouck M. P., Fenart L., Benaissa M., Spik G., Cecchelli R. Pierce A. (1999) Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J. Biol. Chem. 274, 7011 7017.
14. Forloni G., Iussich S., Awan T. et al. (2002) Tetracyclines affect prion infectivity. Proc. Natl Acad. Sci. USA 99, 10849 10854.
15. Gabizon R., McKinley M. P., Groth D. Prusiner S. B. (1988) Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc. Natl Acad. Sci. USA 85, 6617 6621.
16. Gauczynski S., Peyrin J. M., Haik S. et al. (2001) The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 20, 5863 5875.
17. Hachiya N. S., Watanabe K., Sakasegawa Y. Kaneko K. (2004) Microtubules-associated intracellular localization of the NH2-terminal cellular prion protein fragment. Biochem. Biophys. Res. Commun. 313, 818 823.
18. Harrington J. P. (1992) Spectroscopic analysis of the unfolding of transition metal-ion complexes of human lactoferrin and transferrin. Int.J. Biochem. 24, 275 280.
19. Harris D. A., Huber M. T., van Dijken P., Shyng S. L., Chait B. T. Wang R. (1993) Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry 32, 1009 1016.
20. Ishii T., Ishimori H., Mori K., Uto T., Fukuda K., Urashima T. Nishimura M. (2007) Bovine lactoferrin stimulates anchorage-independent cell growth via membrane-associated chondroitin sulfate and heparan sulfate proteoglycans in PC12 cells. J. Pharmacol. Sci. 104, 366 373.
21. Iwamaru Y., Takenouchi T., Ogihara K. et al. (2007) Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion strains. J. Virol. 81, 1524 1547.
22. Ji B., Maeda J., Higuchi M., Inoue K., Akita H., Harashima H. Suhara T. (2006) Pharmacokinetics and brain uptake of lactoferrin in rats. Life Sci. 78, 851 855.
23. Kawamata T., Tooyama I., Yamada T., Walker D. G. McGeer P. L. (1993) Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am. J. Pathol. 142, 1574 1585.
24. Kim C. L., Umetani A., Matsui T., Ishiguro N., Shinagawa M. Horiuchi M. (2004a) Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies. Virology 320, 40 51.
25. Kim C. L., Karino A., Ishiguro N., Shinagawa M., Sato M. Horiuchi M. (2004b) Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation. J. Gen. Virol. 85, 3473 3482.
26. Leucht C., Simoneau S., Rey C., Vana K., Rieger R., Lasmezas C. I. Weiss S. (2003) The 37 kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep. 4, 290 295.
27. Leveugle B., Spik G., Perl D. P., Bouras C., Fillit H. M. Hof P. R. (1994) The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res. 650, 20 31.
28. May B. C., Fafarman A. T., Hong S. B., Rogers M., Deady L. W., Prusiner S. B. Cohen F. E. (2003) Potent inhibition of scrapie prion replication in cultured cells by bis-acridines. Proc. Natl Acad. Sci. USA 100, 3416 34121.
29. Murayama Y., Yoshioka M., Yokoyama T., Iwamaru Y., Imamura M., Masujin K., Yoshiba S. Mohri S. (2007) Efficient in vitro amplification of a mouse-adapted scrapie prion protein. Neurosci. Lett. 413, 270 273.
30. Nishida N., Harris D. A., Vilette D., Laude H., Frobert Y., Grassi J., Casanova D., Milhavet O. Lehmann S. (2000) Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J. Virol. 74, 320 325.
31. Pan K. M., Baldwin M., Nguyen J. et al. (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl Acad. Sci. USA 90, 10962 10966.
32. Pankiewicz J., Prelli F., Sy M. S., Kascsak R. J., Kascsak R. B., Spinner D. S., Carp R. I., Meeker H. C., Sadowski M. Wisniewski T. (2006) Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. Eur. J. Neurosci. 23, 2635 2647.
33. Parkyn C. J., Vermeulen E. G., Mootoosamy R. C. et al. (2008) LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein. J. Cell Sci. 121, 773 783.
34. Pauly P. C. Harris D. A. (1998) Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273, 33107 33110.
35. Pocchiari M., Schmittinger S. Masullo C. (1987) Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. J. Gen. Virol. 68, 219 223.
36. Prusiner S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136 144.
37. Prusiner S. B. (1991) Molecular biology of prion diseases. Science 252, 1515 1522.
38. Schmidt A., Hannah M. J. Huttner W. B. (1997) Synaptic-like microvesicles of neuroendocrine cells originate from a novel compartment that is continuous with the plasma membrane and devoid of transferrin receptor. J. Cell Biol. 137, 445 458.
39. Shimazaki K., Tazume T., Uji K., Tanaka M., Kumura H., Mikawa K. Shimo-Oka T. (1998) Properties of a heparin-binding peptide derived from bovine lactoferrin. J. Dairy Sci. 81, 2841 2849.
40. Shyng S. L., Huber M. T. Harris D. A. (1993) A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J. Biol. Chem. 268, 15922 15928.
41. Stockel J., Safar J., Wallace A. C., Cohen F. E. Prusiner S. B. (1998) Prion protein selectively binds copper(II) ions. Biochemistry. 37, 7185 7193.
42. van der Strate B. W., Beljaars L., Molema G., Harmsen M. C. Meijer D. K. (2001) Antiviral activities of lactoferrin. Antiviral Res. 52, 225 239.
43. Sunyach C., Jen A., Deng J., Fitzgerald K. T., Frobert Y., Grassi J., McCaffrey M. W. Morris R. (2003) The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J. 22, 3591 3601.
44. Supattapone S., Nguyen H. O., Cohen F. E., Prusiner S. B. Scott M. R. (1999) Elimination of prions by branched polyamines and implications for therapeutics. Proc. Natl Acad. Sci. USA 96, 14529 14534.
45. Takase K. (1998) Reactions of denatured proteins with other cellular components to form insoluble aggregates and protection by lactoferrin. FEBS Lett. 441, 271 274.
46. Takayama Y., Takahashi H., Mizumachi K. Takezawa T. (2003) Low density lipoprotein receptor-related protein (LRP) is required for lactoferrin-enhanced collagen gel contractile activity of human fibroblasts. J. Biol. Chem. 278, 22112 22118.
47. Taylor D. R. Hooper N. M. (2007) The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem. J. 402, 17 23.
48. Taylor D. R., Watt N. T., Perera W. S. Hooper N. M. (2005) Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copper-stimulated, clathrin-dependent endocytosis. J. Cell Sci. 118, 5141 5153.
49. Viles J. H., Cohen F. E., Prusiner S. B., Goodin D. B., Wright P. E. Dyson H. J. (1999) Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc. Natl Acad. Sci. USA 96, 2042 2047.
50. Yokoyama T., Kimura K. M., Ushiki Y., Yamada S., Morooka A., Nakashiba T., Sassa T. Itohara S. (2001) In vivo conversion of cellular prion protein to pathogenic isoforms, as monitored by conformation-specific antibodies. J. Biol. Chem. 276, 11265 11271.